Esophageal Reflux Current Events | Esophageal Reflux News | 4
|
| Page
4 of
8 |
150 Results |
|
|
|
Sort By:
Page Views | Date |
Landmark UNC-led study finds radiofrequency ablation is effective treatment for Barrett's esophagus
A landmark clinical trial led by a University of North Carolina at Chapel Hill researcher concludes that radiofrequency ablation is an effective treatment for dysplasia in people with Barrett's esophagus, a condition that can lead to deadly gastrointestinal cancer. view more (2009-05-28)
New study shows erosive esophagitis healing linked to acid control
New clinical data demonstrated, for the first time in a prospective study, a direct relationship between controlling gastric (or stomach) acid and healing erosive esophagitis caused by acid reflux disease. view more (2006-05-23)
How to save cost for esophageal varices?
Patients with cirrhosis of the liver develop abnormally dilated blood vessels in esophagus. These are called esophageal varices. Blood vomiting may occur from the rupture of these varices, which may be fatal, so it is important to eradicate these varices. view more (2008-05-21)
Chronic diarrhea unresponsive to conventional medication: Are you taking lansoprazole?
Lansoprazole is a proton pump inhibitor which powerfully suppresses gastric acid production and is widely prescribed for chronic use in gastroesophageal reflux disease. view more (2009-05-14)
Cardia resection for perforated gastroesophageal cancer
Iatrogenic perforation of cancer of the esophagus or the gastroesophageal (GE) junction is a severe complication. view more (2009-07-08)
New reflux disease technology more comfortable, not more effective
A wireless device that measures the acidity of stomach contents backwashed into the esophagus allows patients to avoid some of the nose pain and throat discomfort associated with the conventional wired monitor used to manage hard-to-treat gastroesophageal reflux disease. view more (2006-07-11)
Radiofrequency ablation is effective treatment for dysplasia in Barrett's esophagus
Interim results from a nationwide clinical trial led by a University of North Carolina at Chapel Hill researcher suggest that radiofrequency ablation is an effective treatment for dysplasia in people with Barrett's esophagus, a condition that can lead to deadly gastrointestinal cancer. view more (2008-05-20)
Link between esophageal cancer and soft drinks debunked by researchers at Yale
Carbonated soft drink consumption was previously suggested to be linked to the 350 percent increase of adenocarcinoma of the esophagus since the mid-1970s. view more (2006-01-04)
New research finds markers for esophageal cancer before it develops
Rhode Island Hospital researchers have identified genetic proteins, also known as biomarkers, capable of distinguishing changes at the microscopic level that can signal a precancerous condition in the esophagus. view more (2008-11-04)
24 Hours Of Misery For Heartburn Sufferers - Sex And Work Are Major Casualties
21 October 2002 - Geneva, Switzerland - New research shows that reflux disease (GERD), which causes heartburn, leads to misery around the clock for many sufferers. The effects of the disease are much more serious than previously thought, impacting not only on eating and drinking habits but also on work performance, social activities and even sex.... view more... (2002-10-21)
A safe, well-tolerated, and effective treatment for metastatic esophageal cancer
Metastatic esophageal squamous cell cancer has very poor prognosis. Conventional surgery is considered the most effective treatment, but many cases are inoperable at the time of diagnosis. view more (2009-02-23)
Study shows more than half of esophageal cancer patients now survive
In part because the nature of the disease has changed, nearly 50 percent of patients with esophageal cancer that undergo an advanced surgical procedure now survive for five years, not 20 percent as once thought view more (2006-04-12)
NYU Langone Medical Center researchers find altered micriobiome prevalent in the diseased esophagus
Gastroesophageal reflux diseases , or GERD, affects about 10 million people in the United States, yet the cause and an unexpected increase in its prevalence over the last three decades remains unexplainable. view more (2009-08-03)
Study finds outcomes of high-risk cancer operations in 80-year-olds worse than reported
New research published in the December issue of The Journal of the American College of Surgeons shows that outcomes of high-risk cancer operations in 80-year-olds are considerably worse than reported in case studies and published survival statistics, which may lead to unrealistic expectations about the safety of these operations in the elderly. view more (2007-12-19)
Chocolate, wine, spicy foods may be OK for heartburn, Stanford study finds
Patients have been known to hug Lauren Gerson, MD, so overjoyed are they at hearing her words. What does she say to them? Go ahead and eat chocolate. Indulge your passion for spicy cuisine. Drink red wine. view more (2006-06-29)
Elevated pepsin levels may lead to rejection of lung transplants
Researchers in the United Kingdom have demonstrated that high levels of pepsin, a digestive enzyme that is a marker for gastric aspiration, are associated with acute rejection of a lung transplant. view more (2007-06-18)
New uses for endoscopy
Braquitherapy guided by ecoendoscopy has enabled a therapeutic approach to injuries, hitherto inaccessible by other means. view more (2006-04-04)
Holiday season could ring in 'heartburn season'
Making merry is often synonymous with overindulging - whether from holiday feasts or rich desserts or alcoholic beverages - ringing in the holiday season as "heartburn season." view more (2006-11-16)
Penn researchers identify natural tumor suppressor
Researchers from the University of Pennsylvania School of Medicine have identified a key step in the formation - and suppression - of esophageal cancers and perhaps carcinomas of the breast, head, and neck. view more (2008-09-10)
Heartburn drugs deemed safe for fetuses according to Ben-Gurion University researchers
H2 Blocker drugs, such as Famotidine, Cimetidine and Ranitidine, approved in the U.S. for acid reflux (heartburn), pose no significant risks for the fetus according to a large collaborative cohort study by researchers at Ben-Gurion University of the Negev. view more (2009-10-08)
|
|
| Page
4 of
8 |
150 Results |
|
|
|
Sort By:
Page Views | Date |
|
